OGS-12 Chemotherapy Regimen for Osteosarcoma
Key Advantages and Toxicity Profile
- The British Journal of Cancer guidelines suggest that high-dose methotrexate requires mandatory inpatient treatment with complex pharmacokinetic monitoring, measurement of methotrexate serum levels, potential dialysis support for toxicity, and rigorous hydration, clinical surveillance, and leucovorin rescue 1, 2, 3
- The Annals of Oncology recommends that approximately 30% of metastatic osteosarcoma patients can become long-term survivors with complete surgical resection, which aligns with the OGS-12 protocol's curative intent in metastatic disease 4, 5, 6